-
Single-cell characterization of anti-LAG3+anti-PD1 treatment in melanoma patients
Study
EGAS00001005580
-
Orthotopic Patient-Derived Organoid Model Reveals Tumor Microenvironment-Dependent Phenotypes in Lung Squamous Cell Carcinoma
Dataset
EGAD50000002915
-
Multi-modal single-cell sequencing dataset for large B cell lymphoma samples
Dataset
EGAD50000002966
-
scRNA-seq data from HNSCC samples before and after BA treatment
Dataset
EGAD50000003043
-
Low-coverage whole-genome sequencing
Dataset
EGAD50000003058
-
Gut microbiota biomarkers associated with Multiple Myeloma: The REMNANT Study
Dataset
EGAD50000003072
-
Norwegian Sarcoma Consortium Tumor-Normal pairs Whole Exome Sequencing dataset 2026
Dataset
EGAD50000003102
-
Carcinoma of Unknown Primary (CUP): A comparison across tissue and liquid biomarkers (CUP-COMP) study
Study
EGAS50000001821
-
A single-cell multi-omic atlas of nodal B-cell non-Hodgkin lymphomas
Study
EGAS50000000342
-
Genomic correlates with survival after treatment of oesophageal adenocarcinoma by surgery alone
Study
EGAS50000002190
-
cfEM-seq methylation sequencing in classic Hodgkin lymphoma
Dataset
EGAD50000002929
-
Nanopore Amplicon Sequencing of 34 uveal melanoma samples (33 patient tumors + 1 primary cell line) in 4 mutational hotspot regions for genotyping
Dataset
EGAD50000003067
-
WES dataset of mesothelioma CONFIRM study
Dataset
EGAD50000002621
-
RNA sequencing dataset of mesothelioma CONFIRM study
Dataset
EGAD50000002622
-
How to use the EGA search box
Documentation
discovery/metadata/search-box
-
Cell-free DNA Whole Genome Sequencing for Non-Invasive Minimal Residual Disease Detection in Multiple Myeloma
Study
EGAS50000002055
-
Visium Spatial transcriptomic profiling of IOKIN samples
Study
EGAS50000002196
-
Whole-Exome Sequencing of Tumor Biopsies from a Colorectal Cancer Patient with Two Distinct Primary Tumors and Matched Metastases
Study
EGAS50000001385
-
Single-cell study of 14 childhood medulloblastoma patients
Study
EGAS00001006392
-
Genomic correlates with survival after treatment of oesophageal adenocarcinoma by surgery alone
Dac
EGAC50000001177
-
Multi-omics analysis revealed clonal evolution of the sarcoma patient-derived xenograft
Study
EGAS50000001860
-
Genomic sequencing in an oesophageal adenocarcinoma cohort
Dataset
EGAD50000003139
-
Whole-genome sequencing of plasma cell-free DNA for non-invasive minimal residual disease detection in multiple myeloma
Dataset
EGAD50000002954
-
Transcriptomic Dataset of avelumab and immune-stimulating agent combination study
Dataset
EGAD50000003119
-
Genomic Datasets of avelumab and immune-stimulating agents combination study
Dataset
EGAD50000003120
-
DLGG sequencing
Study
EGAS50000000841
-
Spatial transcriptomic profiling of INSPIRE samples
Dataset
EGAD50000003130
-
IMDiK–Nencki Glioblastoma Immunotherapy Data Access Committee
Dac
EGAC50000000632
-
Transcription, Whole Exome, and Methylation studies in untreated and MYD88 mutated Waldenstrom's Macroglobulinemia
Dataset
EGAD50000003127
-
WES_sarcoma_PDXs
Dataset
EGAD50000002690
-
RNA_sarcoma_PDXs
Dataset
EGAD50000002691
-
Prognostic value of intra-tumoral heterogeneity in stage II colorectal mucinous adenocarcinoma
Study
EGAS50000002201
-
Structural Forms of ERBB2 Amplification and Their Clinical Significance in EAC Brain Metastases
Study
EGAS50000001593
-
Multiomic data from esophageal adenocarcinoma brain metastases
Dac
EGAC50000000899
-
Germline ALK variant in patient with neurodisability and neuroblastoma
Study
EGAS50000001885
-
Universidad Autónoma de Madrid Human Behavioural Genetics Data Access Committee
Dac
EGAC50000001178
-
Comprehensive DNA and RNA profiling of relapsed interdigitating dendritic cell sarcoma in a patient achieving durable remission after autologous stem cell transplantation
Study
EGAS50000002220
-
Cellular plasticity drives regeneration of heterogeneity in hepatocellular carcinoma organoids
Study
EGAS50000002198
-
Whole genome sequencing data of high-grade serous ovarian cancer samples (set 18)
Dataset
EGAD50000002796
-
Spatial transcriptomic profiling of IOKIN samples
Dataset
EGAD50000003147
-
Evaluation of an ex vivo immunotherapy platform using EV-primed immune cells and patient-derived glioblastoma spheroids
Study
EGAS50000001124
-
Bleomycin Induced Pneumonitis cohort of the Exceptional Responders Program of the Garvan Institute of Medical Research
Study
EGAS50000001545
-
Spatial Analysis of IPMNs Defines a Paradoxical KRT17-Positive, Low-Grade Epithelial Population Harboring Malignant Features
Study
phs004497
-
NCTN: An Intergroup Phase III Randomized Controlled Trial Comparing Melphalan, Prednisone and Thalidomide (MPT) vs Melphalan, Prednisone and Lenalidomide (Revlimid) (MPR) in Multiple Myeloma Patients Who Are Not Candidates for High-Dose Therapy (E1A06)
Study
phs004394
-
CIDR: Whole Exome Sequencing of Multiple Myeloma
Study
phs002497
-
NCTN: Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma (ANBL0532)
Study
phs004133
-
NCTN: Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma (ANBL0531)
Study
phs004138
-
Resuscitation Outcomes Consortium Prehospital Tranexamic Acid Use for Traumatic Brain Injury (ROC-TXA-BioLINCC)
Study
phs004873
-
NCTN: A Randomized Phase III Trial of Three Different Regimens of CPT-11 Plus 5-Fluorouracil and Leucovorin Compared to 5-Fluorouracil and Leucovorin in Patients with Advanced Adenocarcinoma of the Colon and Rectum (N9741)
Study
phs004259
-
Defining Intrinsic and Acquired Mechanisms of Immune Checkpoint Blockade Resistance in Glioblastoma
Study
phs003614
-
Derivation of Doxorubicin Mutational Signatures in Cancer
Study
phs004740
-
Natural History Study of Non-A, Non-B Post-Transfusion Hepatitis (NANB-TAH_BioLINCC)
Study
phs004538
-
Immune Contexture of Colorectal Adenomas and Serrated Polyps
Study
phs004106
-
Long-Read Sequencing of Ovarian Cancer Organoids
Study
phs004795
-
A091401 Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Patients With Metastatic or Unresectable Sarcoma
Study
phs003785
-
Childhood Cancer Data Initiative (CCDI): A Cohort of Hispanic Children with Acute Lymphoblastic Leukemia; Bloom Syndrome in a Mexican American Family with Rhabdomyosarcoma
Study
phs002823
-
Therapeutic Hypothermia After Pediatric Cardiac Arrest (Out of Hospital) (THAPCA-OH-BioLINCC)
Study
phs004646
-
Blood and Marrow Clinical Trials Network - A Multi-center Phase II Trial Randomizing Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN-1203-BioLINCC)
Study
phs004709
-
The Critical Role of the Host Endogenous Immune Compartment After Intracerebroventricular CAR T-Cell Therapy in Recurrent GBM
Study
phs004571
-
Multiregion Biopsies and Corresponding Neurosphere Cultures Reveal Spatial Divergence in Glioblastoma
Study
phs004410
-
NCTN: A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma (CALGB-90601)
Study
phs004243
-
NCTN: A Randomized Phase III Study of Ibrutinib (PCI-32765)-Based Therapy vs Standard Fludarabine, Cyclophosphamide, and Rituximab (FCR) Chemoimmunotherapy in Untreated Younger Patients With Chronic Lymphocytic Leukemia (CLL) (E1912)
Study
phs004233
-
Correlative Studies in Protocol GU16-287, which Studied Gemcitabine + (Carboplatin or Oxaliplatin) + Nivolumab in Metastatic Urothelial Cancer, which Included Collaboration with CIMAC-CIDC (Cohort 1 of 3)
Study
phs004060
-
Blood and Marrow Transplant Clinical Trials Network A Trial of Single Autologous Transplant With or Without Consolidation Therapy Versus Tandem Autologous Transplant With Lenalidomide Maintenance for Patients With Multiple Myeloma (BMT CTN-0702-BioLINCC)
Study
phs004692
-
Fusion Transcription Factor Dosage Controls Cell State in Rhabdomyosarcoma
Study
phs004381
-
Childhood Cancer Data Initiative (CCDI): Whole Genome Landscapes of Patient Derived Osteosarcoma Xenograft Models
Study
phs004232
-
Effector CD4 T Cells Convert Transient Responses to KRAS-Targeted Therapy into Long-Term Durable Remissions in Pancreatic Cancer
Study
phs004509
-
Blood and Marrow Transplant Clinical Trials Network - A Phase II Multicenter Trial of Single Autologous Hematopoietic Cell Transplant Followed by Lenalidomide Maintenance for Multiple Myeloma with or without Vaccination with Dendritic Cell/Myeloma Fusions (BMT CTN-1401-BioLINCC)
Study
phs004718
-
The Electronic Medical Records and GEnomics Network Genomic Risk Assessment (eMERGE IV)
Study
phs003905
-
IMPACT Study: Single-Cell RNA-Seq before and after Vaccination for SARS-CoV-2 in Patients with Multiple Myeloma and its Precursor Conditions
Study
phs004542
-
NCTN: A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) With or Without Cetuximab (C225) After Curative Resection for Patients With Stage III Colon Cancer (N0147)
Study
phs004241
-
Blood and Marrow Clinical Trials Network - A Multi-Center, Phase III, Randomized Trial of RIC, and Transplantation of (dUCB) Versus HLA-Haplo Related Bone Marrow for Patients with Hematologic Malignancies (BMT CTN-1101-BioLINCC)
Study
phs004698
-
Feasibility of Circulating 5-Hydroxymethylcytosine Profiling in Osteosarcoma
Study
phs003842
-
Cancer Associated Fibroblasts Drive Epithelial to Mesenchymal Transition and Classical to Basal Change in Pancreatic Cancer Cells with Loss of IL-8 Expression
Study
phs004499
-
Childhood Cancer Data Initiative (CCDI): CCDI Pediatric In Vivo Testing Program - Orthotopic CNS Tumors
Study
phs003162
-
Impact of HLA Aberrations on Tumor Neoepitope Presentation
Study
phs004529
-
Exome and Multi-Site Bulk and scRNA-seq Profiling of Pleural Mesothelioma
Study
phs004285
-
HRDetect in Tubo-Ovarian Carcinoma: Stratification and Therapeutic Implications
Study
phs004452
-
Functional Genomics and Tumor Microenvironment Analysis Reveal Prognostic Biological Subtypes in Mantle Cell Lymphoma
Study
phs003849
-
Cellular and Molecular Profiling of Epithelial Ovarian Cancers and Associated Normal Tissues
Study
phs004702
-
Blood and Marrow Clinical Trials Network Trial of Non-Myeloablative Conditioning and Transplantation of Umbilical Cord Blood For Hematologic Malignancies (BMT CTN-0604-BioLINCC)
Study
phs004890
-
BTC GBM TeamLab Trial 1: Longitudinal Tissue Profiling of Recurrent Malignant Glioma During Repeat Dosing of Oncolytic Viral Immunotherapy (NCT03152318)
Study
phs004189
-
scRNAseq of Human Urothelial Carcinoma
Study
phs003405
-
5-Hydroxymethylcytosine Profiling of Cell-Free DNA Disease Detection in High-Risk Relapsed or Refractory Neuroblastoma
Study
phs004894
-
Dissecting the Role of the Microenvironment in Follicular Lymphoma Transformation
Study
phs004175
-
Correlative Studies in Protocol E4412, which Studied Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Hodgkin Lymphoma, in Collaboration with CIMAC-CIDC
Study
phs003450
-
Integrating Contemporary Biospecimens and Immunomethylomics into the study of the Glioma Genetics and Immunity - CIDR
Study
phs003990
-
Genome-Wide Association Study for Glucocorticoid-Induced Ocular Hypertension
Study
phs004037
-
MP2PRT: Discovering Biomarkers of Outcome: EBV DNA Quantification and the Relationship of EBV and LINE1 Retrotransposon Expression in Pediatric Patients With Nasopharyngeal Carcinoma (NPC) Enrolled on ARAR0331
Study
phs003092
-
Clonal Heterogeneity in Human Pancreatic Ductal Adenocarcinoma and Its Impact on Tumor Progression
Study
phs004079
-
Efficacy of the ATR Inhibitor Ceralasertib in Patients with ARID1A-Deficient Gynecologic and Other Solid Tumor Malignancies
Study
phs004471
-
Phase II Study of Single-Agent Daratumumab in Patients with High-Risk Monoclonal Gammopathy of Undetermined Significance (MGUS) and Low-Risk Smoldering Multiple Myeloma (SMM)
Study
phs004127
-
NCTN: Phase III Randomized Study of Sorafenib Plus Doxorubicin versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma (HCC) (CALGB-80802)
Study
phs004239
-
SMARCB1 Missense Mutants Destabilize SWI/SNF Complex Stability and Remodeling Activity
Study
phs003896
-
Kids First: Childhood Cancer Data Initiative (CCDI) - Discovering the Timing and Origins of Bone and Soft Tissue Cancers
Study
phs002827
-
NCTN: A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children with Newly Diagnosed High Risk Hodgkin Lymphoma (AHOD0831)
Study
phs004161
-
Out-of-Frame CBX3::ALK Fusion Drives ALK Activation and Therapy Response
Study
phs004503
-
NCTN: A Randomized Phase III Trial of CC-5013 (Lenalidomide) and Low Dose Dexamethasone (LLD) versus Bortezomib, Lenalidomide and Low Dose Dexamethasone (BLLD) for Induction, in Patients with Previously Untreated Multiple Myeloma (S0777)
Study
phs004247
-
Molecular Markers of Risk of Subsequent Invasive Breast Cancer in Women with Ductal Carcinoma in Situ
Study
phs004440
-
Women's Health Initiative (WHI) - Life and Longevity After Cancer (LILAC) (WHI-LILAC-BioLINCC)
Study
phs004174